HO Jin KIM

Executive Vice President | Head of Developmemt

Incheon, South Korea

About

Strategic Leader in Cell Therapy & Stem Cell Commercialization ​With 23 years in biology and 20 years dedicated to stem cell development, I serve as Vice President and Head of Development. I specialize in the full-cycle commercialization of cell therapies, bridging the gap between innovative R&D and market success. ​ ​Strategic Business Direction: Designing product roadmaps and identifying commercial opportunities to maximize market value. ​Full-Cycle Leadership: Overseeing the entire process from early R&D and Process Development (PD) to GMP technology transfer and clinical trial readiness. ​Operational Excellence: Achieving critical milestones by optimizing GMP-compliant manufacturing and regulatory strategies. ​I am committed to transforming scientific breakthroughs into successful medical realities by integrating high-potency products with robust commercial strategies.

Experience

  • EpiBiotech ()
    • 개발본부 부사장
      Jul 2025 - Present · 1 yr 1 mo

    • Director of Developmemt
      May 2025 - Jun 2025 · 2 mos

    • Division Director | Managing Director
      Mar 2025 - May 2025 · 3 mos

  • Cellatoz Therapeutics lnc. ()
    • Vice President
      Jan 2024 - Mar 2025 · 1 yr 3 mos

    • Senior Managing Director
      Jan 2022 - Dec 2023 · 2 yrs

    • Managing director
      Oct 2019 - Dec 2021 · 2 yrs 3 mos

  • CHAbiotech ()
    • General Manager
      Jan 2017 - Sep 2017 · 9 mos

    • Deputy Senior Manager
      Apr 2013 - Dec 2016 · 3 yrs 9 mos

  • Senior Researcher at CHA University 차의과학대학교
    Aug 2010 - Mar 2013 · 2 yrs 8 mos

  • Senior Researcher at Ewha Womans University
    Aug 2006 - Jul 2010 · 4 yrs